Rep. Lisa C. McClain Buys Humana Inc. (NYSE:HUM) Shares

Representative Lisa C. McClain (R-Michigan) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on June 24th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Autoliv (NYSE:ALV) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/4/2025.
• Sold $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of XPO (NYSE:XPO) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Lithia Motors (NYSE:LAD) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Sanofi (NASDAQ:SNY) on 7/22/2025.
• Sold $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of Group 1 Automotive (NYSE:GPI) on 7/22/2025.

Humana Stock Up 0.5%

Shares of HUM opened at $287.75 on Tuesday. The firm has a market cap of $34.61 billion, a P/E ratio of 22.08, a price-to-earnings-growth ratio of 1.68 and a beta of 0.44. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $382.72. The company’s 50-day moving average price is $243.80 and its 200 day moving average price is $253.20. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.96 earnings per share. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HUM. Raymond James Financial upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Piper Sandler reduced their price objective on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company reduced their price target on shares of Humana from $348.00 to $344.00 and set an “overweight” rating on the stock in a research report on Thursday, August 14th. Morgan Stanley dropped their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $281.43.

Hedge Funds Weigh In On Humana

A number of institutional investors and hedge funds have recently made changes to their positions in HUM. Revolve Wealth Partners LLC purchased a new position in Humana in the fourth quarter valued at approximately $202,000. Raymond James Financial Inc. purchased a new position in Humana in the fourth quarter valued at approximately $26,720,000. Scotia Capital Inc. increased its stake in Humana by 44.2% in the fourth quarter. Scotia Capital Inc. now owns 953 shares of the insurance provider’s stock valued at $242,000 after purchasing an additional 292 shares during the last quarter. SageView Advisory Group LLC purchased a new position in Humana in the fourth quarter valued at approximately $346,000. Finally, Mariner LLC increased its stake in Humana by 4.0% in the fourth quarter. Mariner LLC now owns 13,461 shares of the insurance provider’s stock valued at $3,415,000 after purchasing an additional 517 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.